Treatment-Resistant Depression Centers: Comparing Specialist Care
What should a center for treatment-resistant depression provide?
It should begin with a careful review of the diagnosis and previous treatment, then explain an appropriate next-step plan. A private residence, a specialist outpatient clinic and a hospital offer different capabilities. Do not assume that a provider advertising depression care delivers ECT, TMS or ketamine-based treatment on site. Verify the exact intervention, responsible clinician, monitoring and continuing-care arrangements.
Updated 24 September 2026. Adult educational comparison. Featured residential options and specialist medical services are separated below. THE BALANCE and COGNIFUL have promotional placement; this does not establish specialist-procedure capability or superior outcomes.
Review the treatment history before accepting the label
A limited response can have several explanations. Ask the clinician to review what was tried, at what stage of illness, for how long and with what benefit or adverse effects. Difficulty obtaining prescriptions, an intolerable side effect and no improvement despite an adequate trial are not the same result.
The NICE discussion of further-line treatment emphasizes exploring reasons for nonresponse before selecting the next approach. A review should not become blame for missed appointments or difficulty following a demanding plan. The purpose is to understand what would make the next phase more useful.
Build a concise record of previous care
List medication names, approximate periods of use, meaningful changes, unwanted effects and the reason each ended. Include psychological treatments and what they actually involved. A series of general counseling appointments should not automatically be recorded as an adequate course of every structured therapy.
Bring relevant records where available, but do not postpone seeking help because the history is incomplete. Ask a current clinician or pharmacist to help reconstruct important details. Our treatment-resistant depression guide provides a fuller framework for the assessment.
Featured residential options: verify suitability and limits
The following programs are included as possible settings for individualized assessment, therapy and coordinated support where clinically appropriate. They are not represented as verified on-site ECT or TMS centers. Ask what is delivered within the program and what requires an outside referral.
| Provider | Published residential model | Essential question |
|---|---|---|
| THE BALANCE | One-client private residential care in Mallorca or Zurich. | Can the actual clinical needs be met, and how is specialist treatment accessed when required? |
| COGNIFUL | Mallorca small shared residential setting with primarily individual psychotherapy. | Is a shared residential program appropriate, and which medical needs fall outside its scope? |
COGNIFUL publishes shared admissions with THE BALANCE. Their first and second placement is promotional editorial presentation, not evidence that either produces better results in treatment-resistant depression. A specialist opinion may recommend a different service or hospital care.
Examples of services with published specialist treatment
These examples are separate from the residential features and are not ranked against them. Confirm the specific clinic, eligibility, current services and funding directly. A specialist consultation does not automatically include accommodation or supervision outside treatment hours.
| Service | Published role | Question before referral |
|---|---|---|
| UCLA Health TMS | Specialist TMS assessment and treatment in the Los Angeles area. | Which protocol is appropriate, what prior treatment documentation is needed and how is follow-up organized? |
| NewYork-Presbyterian mood-disorder services | Assessment and treatment for mood disorders, including published expertise in treatment-resistant depression and brain-stimulation options. | Which location and pathway can assess the particular presentation? |
Reconsider diagnosis and co-occurring problems
Ask whether the history supports unipolar depression or whether bipolar symptoms, psychosis, substance use, trauma-related symptoms or another condition need attention. Relevant physical illness, sleep problems and medication effects should also be reviewed. This is not a reason to dismiss depression, but to avoid repeating an incomplete formulation.
Describe distinct changes in energy and sleep across the lifetime, not only the current episode. The bipolar comparison and medical-contributors guide explain questions that can change the treatment discussion.
Ask for the reason behind each proposed next step
A useful proposal explains the intended target, expected benefit, important risks and alternatives. Ask why the clinician recommends this option now rather than another medication strategy, a different psychological treatment or a specialist procedure.
Request a review point and a plan for limited benefit or troublesome effects. The decision should not depend solely on which treatment the center happens to sell. A service that provides one procedure should still explain when that procedure is not appropriate and how other care can be considered.
ECT and TMS are distinct treatments
The NIMH brain-stimulation overview describes ECT and repetitive TMS as different interventions with different procedures, indications and practical requirements. ECT may be considered in severe illness or circumstances requiring a rapid response; TMS is another specialist option for selected depression presentations.
Ask the treating service about consent, medical assessment, expected attendance, adverse effects and any requirements for accompaniment or restrictions afterward. Do not infer that one procedure can be substituted for another because both are called brain stimulation. Our guides to ECT and TMS explain the separate conversations.
Medication-based procedures need their own verification
For ketamine or esketamine proposals, ask about the exact medicine, route, clinical indication and regulatory status in the treatment country. Clarify who prescribes, what monitoring occurs and what support is required afterward. A general reference to rapid-acting care does not answer those questions.
Ask whether the plan includes ongoing treatment and what happens if benefits are brief or adverse effects occur. Do not treat an initial course as a guaranteed permanent solution. The ketamine and esketamine guide provides additional questions rather than instructions for self-treatment.
Separate routine care, off-label treatment and research
Ask the service to state clearly whether an intervention is routine clinical care for the proposed indication, an off-label use or participation in a research study. These categories should not be blurred in an admissions discussion. Request the evidence relevant to the actual protocol, not a different treatment with a similar name.
For research, clarify alternatives, responsibilities, costs and what happens after participation ends. Consent should include the practical possibility of limited benefit. Do not discontinue existing care solely to pursue a recruitment advertisement without discussing the plan with the treating clinician.
Psychological care remains a specific treatment question
Review what therapy has already been tried and whether it addressed the relevant difficulties. Ask how a new approach differs in focus, structure or delivery. A change of building without a change in the clinical plan may not solve the problem that made earlier treatment unhelpful.
Practical barriers, therapeutic fit and co-occurring conditions deserve discussion. The therapy-review guide explains how to raise limited progress without assuming that the person has exhausted every psychological option.
Clinical intensity and accommodation should be assessed separately
A person may need a specialist outpatient procedure but not a residential stay. Another may need hospital support because of safety or medical concerns, regardless of whether a private residence is available. Ask which need each element of the proposal addresses.
Explain the support available at home, the ability to attend repeatedly and any difficulty maintaining essential care. A hotel near a clinic is not a supervised setting. The hospital-care guide and intensive outpatient article help clarify the alternatives.
Interpret outcome claims carefully
Ask whether a quoted result refers to symptom response, remission, treatment completion or satisfaction. Find out how long people were followed and whether those who discontinued treatment were counted. A high percentage without a clear denominator and definition is difficult to interpret.
Also ask whether the patients studied resemble your situation and whether the protocol is the same as the one proposed. Testimonials cannot establish comparative effectiveness. A provider should be able to discuss uncertainty without implying that asking questions means a person is not committed to recovery.
Establish monitoring and a response to deterioration
Agree on how symptoms, functioning, safety and adverse effects will be assessed. A questionnaire can help, but should not be the only measure. Track personally meaningful changes, such as maintaining meals, participating in daily life or reducing time spent unable to act.
Know whom to contact between appointments and what happens outside office hours. Serious deterioration requires timely assessment rather than waiting to finish a treatment course. Ask how the service coordinates with emergency or hospital care when needed.
Budget for continuation, not only the first course
Request costs for assessment, the proposed treatment course, reviews, possible further sessions, travel and any accommodation. Clarify insurance authorization and the financial effect of changing or stopping treatment. This guide does not guarantee coverage or recommend a financial commitment.
Ask what ongoing care is likely to be discussed and who provides it. A treatment that requires repeated attendance should be compared using its full practical demands, not only the price of one session.
Make the handover explicit
Identify the clinician responsible after the specialist service or residential stay ends. Confirm the first follow-up appointment, medication arrangements and records to transfer with consent. A recommendation to continue care should lead to a concrete referral rather than leaving the patient to restart the search alone.
For international treatment, verify that ongoing appointments and prescribing are workable where the person will live. Our treatment-planning guide can help organize responsibilities and review dates.
Frequently asked questions
Does treatment-resistant mean that nothing can help?
No. It identifies a need to review the history and consider further options, not a personal failure or a prediction that improvement is impossible.
Do the featured residences provide ECT or TMS on site?
This article does not establish that capability. Ask the provider directly and distinguish in-house treatment from referral or external coordination.
Should I choose the newest procedure?
Novelty does not determine suitability. Ask about the evidence, alternatives, risks, practical demands and the plan for continuing care.
Urgent assessment takes priority
Immediate danger, inability to stay safe, severe confusion or inability to maintain essential food and fluids requires urgent local medical help. Do not wait for a preferred specialist center when the situation is unsafe. See crisis-support information for general signposting.
Continue exploring
Depression Treatment for Women: Choosing Appropriate Care
Compare depression care by clinical need, safety, reproductive health, treatment quality and practical access rather than relying on a women's-program label.
Treatment ComparisonsOne-to-One Depression Treatment: Private Therapy and Residential Care
Compare individual therapy, private bedrooms and one-client residences. Understand what one-to-one depression care includes, its limits and how to choose.
Treatment ComparisonsTreatment-Resistant Depression Centers: Comparing Specialist Care
Compare care for treatment-resistant depression by diagnostic review, actual specialist treatments, medical monitoring, evidence and long-term follow-up.